View in EDS

Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy.

Saved in:
Bibliographic Details
Title: Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy.
Authors: Pacheco FS; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., da Rocha Mota RG; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Pinho Jannini de Sá YA; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Hogaboam CM; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA., Castro-Faria-Neto HC; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Carvalho VF; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; INOVA-IOC Network on Neuroimmunomodulation, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.
Source: Neuroimmunomodulation [Neuroimmunomodulation] 2026; Vol. 33 (1), pp. 213-224. Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article; Review
Journal Info: Publisher: S. Karger Medical and Scientific Publishers Country of Publication: Switzerland NLM ID: 9422763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0216 (Electronic) Linking ISSN: 10217401 NLM ISO Abbreviation: Neuroimmunomodulation Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41915598
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pacheco+FS%22">Pacheco FS</searchLink>; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22da+Rocha+Mota+RG%22">da Rocha Mota RG</searchLink>; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Pinho+Jannini+de+Sá+YA%22">Pinho Jannini de Sá YA</searchLink>; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Hogaboam+CM%22">Hogaboam CM</searchLink>; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Castro-Faria-Neto+HC%22">Castro-Faria-Neto HC</searchLink>; Laboratory of Immunopharmacology, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Carvalho+VF%22">Carvalho VF</searchLink>; Laboratory of Inflammation, Center for Research, Innovation, and Surveillance in Covid-19 and Health Emergencies, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; Rio de Janeiro Research Network on Neuroinflammation (RENEURIN), Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.; INOVA-IOC Network on Neuroimmunomodulation, Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, vinicius.frias@fiocruz.br.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229422763%22">Neuroimmunomodulation</searchLink> [Neuroimmunomodulation] 2026; Vol. 33 (1), pp. 213-224. <i>Date of Electronic Publication: </i>2026 Mar 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger+Medical+and+Scientific+Publishers%22">S. Karger Medical and Scientific Publishers </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9422763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1423-0216 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210217401%22">10217401 </searchLink><i>NLM ISO Abbreviation: </i>Neuroimmunomodulation <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41915598
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000551742
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 213
    Titles:
      – TitleFull: Glucocorticoids and Neutrophil Biology: Impact on the Development of Resistance to Glucocorticoid Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pacheco FS
      – PersonEntity:
          Name:
            NameFull: da Rocha Mota RG
      – PersonEntity:
          Name:
            NameFull: Pinho Jannini de Sá YA
      – PersonEntity:
          Name:
            NameFull: Hogaboam CM
      – PersonEntity:
          Name:
            NameFull: Castro-Faria-Neto HC
      – PersonEntity:
          Name:
            NameFull: Carvalho VF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1423-0216
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Neuroimmunomodulation
              Type: main
ResultId 1